Financials Intensity Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-16 pm EST			5-day change	1st Jan Change
0.4083 ^USD	-2.34%		-5.94%	-0.46%

Jan. 13	Intensity Therapeutics highlights 2025 milestones and outlines 2026 strategic priorities	RE
Dec. 11	Intensity Therapeutics, Inc. to Present Two Posters At the 2025 San Antonio Breast Cancer Symposium	CI

Fiscal Period: December	2022	2023	2024	2025	2026	2027
Net sales ¹	-	-	-	-	-	0.351
Change	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-
Change	-	-	-	-	-	-
EBIT ¹	-	-8.319	-16.58	-11.64	-12.43	-15.94
Change	-	-	-99.36%	29.79%	-6.78%	-28.19%
Interest Paid	-	-0.305	-	-	-	-
Earnings before Tax (EBT) ¹	-	-10.54	-16.27	-11.44	-12.62	-13.55
Change	-	-	-54.37%	29.7%	-10.32%	-7.42%
Net income ¹	-7.582	-11.86	-16.27	-11.3	-12.32	-15.9
Change	-	-56.45%	-37.14%	30.53%	-9.01%	-29.06%
Announcement Date	5/18/23	3/14/24	3/13/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-1.222	-2.491	-3.353	-	-5.069	-3.57	-3.203	-3.394	-2.705	-2.733	-2.808	-3.08	-3.13	-3.24	-
Change	-	-103.86%	-34.62%	-	-	29.57%	10.28%	-5.96%	20.3%	-1.04%	-2.74%	-9.69%	-1.62%	-3.51%	-
Charge d'intérêts	-0.2218	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-3.701	-2.33	-3.171	-	-4.971	-3.513	-3.181	-3.347	-2.537	-2.671	-2.881	-	-	-	-
Change	-	37.04%	-36.12%	-	-	29.33%	9.45%	-5.22%	24.2%	-5.28%	-7.87%	-	-	-	-
Net income ¹	-3.701	-2.33	-4.495	-	-4.971	-3.513	-3.181	-3.347	-2.537	-2.671	-2.758	-3	-3	-3.2	-
Change	-	37.04%	-92.95%	-	-	29.33%	9.45%	-5.22%	24.2%	-5.28%	-3.25%	-8.78%	0%	-6.67%	-
Announcement Date	8/14/23	11/13/23	3/14/24	5/9/24	8/8/24	11/13/24	3/13/25	5/13/25	8/7/25	11/6/25	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-
Change	-	-	-	-	-	-
Announcement Date	5/18/23	3/14/24	3/13/25	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024
CAPEX ¹	-	-	-	-	-
Change	-	-	-	-	-
Free Cash Flow (FCF) ¹	-3.227	-3.971	-2.744	-2.77	-9.539
Change	-	-23.07%	30.91%	-0.96%	-244.35%
Announcement Date	9/20/21	4/20/22	5/18/23	3/14/24	3/13/25

¹USD in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-	-	-4,540.81%
EBT Margin (%)	-	-	-	-	-	-	-	-	-3,860.83%
Net margin (%)	-	-	-	-	-	-	-	-	-4,530.13%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-	-40.77%	-65.19%	-136.81%	-54.58%	-93.9%	-	-	-
ROE	-	-75.07%	-161.84%	401.02%	-261.36%	-202.34%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-1.16x	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-0.8362	-1.094	-0.26	-	-
Change	-	-	-	-	-	-30.88%	76.24%	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-	-	-2.22	-1.38	-1.17	-0.344	-0.215	-0.2525
Change	-	-	-	-	37.84%	15.22%	70.6%	37.5%	-17.44%
Nbr of stocks (in thousands)	-	-	-	-	13,709	15,105	60,065	60,065	60,065
Announcement Date	-	-	-	5/18/23	3/14/24	3/13/25	-	-	-